Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4549313 | 5712418 | I | 4549313-3 | 20040610 | 20040614 | 20041230 | PER | 04-06-0860 | IVAX PHARMACEUTICALS, INC. | 47 | YR | M | N | 20040616 | PH |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4549313 | 1005569634 | PS | CLOZAPINE | 1 | ORAL | 300MG QD ORAL | D | D | 74949 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4549313 | 1005569634 | BIPOLAR DISORDER |
| 4549313 | 1005569634 | SCHIZOAFFECTIVE DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4549313 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4549313 | HYPERGLYCAEMIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4549313 | HP |
| 4549313 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4549313 | 1005569634 | 20040401 |